3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
4
Sarcoma
1
Conditions
Sarcoma, Kaposi
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Carcinoma, Basal Cell
1
Interventions
pembrolizumab
2
Specimen Handling
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
tocilizumab
1
poly ICLC
1
flt3 ligand protein
1
daromun
1
SUB1 protein, human
1
Radiotherapy
1
Radiation
1
Mohs Surgery
1
Melphalan
1
Ipilimumab
1
IPI-926
1
Capecitabine
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Basal Cell
×
daromun
×
Sarcoma
×
Clear all
NCT05329792
2023-10-06
IntriNSiC
Philogen S.p.A.
Phase 2
Unknown
70 enrolled